Original price was: $1,349.00.Current price is: $360.00.

USCAP Dermatopathology in the Desert: Pragmatic Approach to Diagnostic Challenges 2022 (Videos)

Mastering the Diagnosis of Neoplastic and Non-Neoplastic Disorders in Pathology

The accurate diagnosis of neoplastic and non-neoplastic disorders is a significant challenge in pathology, with errors in skin biopsy interpretation, particularly in relation to melanocytic tumors, being a leading cause of litigation in surgical pathology. As a diagnostic pathologist, it is essential to be aware of the numerous pitfalls that can lead to misdiagnosis, including the lack of relevant clinical information, sampling errors, and the wide morphologic spectrum of both inflammatory and neoplastic disorders, which often exhibit overlapping findings and subtle differentiating features.

A precise diagnosis is crucial in initiating appropriate treatment, and staying updated on recent developments in dermatopathology is vital in achieving this goal. This educational activity brings together expert faculty to focus on the diagnosis of melanocytic tumor pathology, mesenchymal tumor pathology, cutaneous lymphomas, and histiocytoses, as well as inflammatory dermatoses.

Target Audience

  • Practicing academic and community pathologists
  • Pathologists-in-training

Learning Objectives

Upon completion of this educational activity, learners will be able to:

  • Understand the wide morphologic spectrum of cutaneous tumors and associated diagnostic challenges
  • Learn about recent developments in dermatopathology
  • Integrate clinical information and ancillary tests for better and more accurate diagnoses

Course Topics

  • Mesenchymal Tumors – Thomas Brenn, MD, PhD
  • Inflammatory Dermatoses – Ryanne Brown, MD, MBA
  • Melanocytic Tumors – Klaus Busam, MD
  • Cutaneous Lymphomas and Histiocytoses – Alejandro Gru, MD
  • Novel Developments in Melanocytic Tumor Pathology – Klaus J. Busam, MD

Original release date: October 19, 2022

Access to this course expires on: September 28, 2025

Additional information

Author